A Comparison of Epinephrine Only, Arginine Vasopressin Only, and Epinephrine Followed by Arginine Vasopressin on the Survival Rate in a Rat Model of Anaphylactic Shock
Authors:
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 106 (5) , 977-983
Abstract
ANAPHYLACTIC shock occurring during anesthesia is lethal in 3–10% of patients even in previously healthy individuals and despite therapy that is consistent with the current guidelines.1–3 Epinephrine is considered in most guidelines1 4,5 as the first-line treatment of anaphylactic shock. In some cases, alternative therapies are used, such as norepinephrine6 or metaraminol,7,8 or more recently arginine vasopressin (AVP).9–11 Although, AVP has been used in several case reports and is considered as effective, there are many unanswered questions regarding its use in patients with anaphylactic shock and particularly in those with anaphylactic shock occurring during anesthesia. In a previous experimental study,12 we demonstrated that AVP could increase mean arterial pressure (MAP) values in rats that underwent anaphylactic shock. This increase in MAP values after anaphylactic shock was comparable to that obtained with epinephrine, but at the highest AVP doses, it was associated with significantly lower skeletal muscle oxygen pressure (Ptio2) values, a parameter that was shown in human and experimental shock states to be correlated with survival.13–16Keywords
This publication has 1 reference indexed in Scilit: